Entry Detail



General Information

Database ID:exR0840261
RNA Name:hsa-miR-652-3p
RNA Type:miRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):110055389End Site(bp):110055409
External Links:hsa-miR-652-3p



Disease Information

Disease Name:Prostate Cancer
Disease Category:Cancers
MeSH ID:D011471
Type:Neoplasms/Digestive System Neoplasms
Alias:Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate



Expression Detail

GEO ID:GSE71008
Description:Plasma extracellular RNA profiles in healthy and cancer patients
Experimental Design:Cancer vs Control
Case Disease Type:Colorectal Cancer
Case Disease SubType:NA
Case Sample:Prostate Cancer
Control Sample:Healthy
Number of Case:100
Number of Control:50
Number of Samples:150





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
FASN
chr17
82078338
82098294
-
RTL8A
chrX
135050932
135052196
-
RTL8B
chrX
135020513
135022542
-
TAGLN2
chr1
159918107
159925732
-
AFDN
chr6
167826922
167972023
+
TUBA1B
chr12
49127782
49131397
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010442.1
chr5
466124
473098
-
NEAT1
chr11
65422774
65445540
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:26786760
Title:Plasma extracellular RNA profiles in healthy and cancer patients
Author:Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, Tsai S, Kohli M, Boardman L, Patel T, Wang L
Journal:Sci Rep. 2016 Jan 20;6:19413.
Description:we performed RNA sequencing analysis on plasma extracellular vesicles derived from 50 healthy individuals and 142 cancer patients.